Aspiration pneumonia medical therapy

Revision as of 17:44, 24 March 2018 by Medhat (talk | contribs)
Jump to navigation Jump to search

Aspiration pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aspiration Pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Aspiration pneumonia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aspiration pneumonia medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aspiration pneumonia medical therapy

CDC onAspiration pneumonia medical therapy

Aspiration pneumonia medical therapy in the news

Blogs on Aspiration pneumonia medical therapy

Directions to Hospitals Treating Pneumonia

Risk calculators and risk factors for Aspiration pneumonia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Medical Therapy

  • Management of patients with swallowing dysfunction is highly individualized based on the cause of the dysfunction.
  • Total parenteral nutrition or nasogastric tube feeding may be necessary to safely meet caloric requirements when the patient's swallowing dysfunction is secondary to a transient disease, such as a critical illness.

Feeding decisions

  • The goals of therapy are safe and efficient nutrition that preserves stable respiratory function and appropriate growth.
  • Oral feeding, while always desirable, is not always the most reasonable goal for patients with severe swallowing dysfunction because the risks of oral feeding may outweigh the psychosocial benefits to the patient and family [6,37,38].
  • On the other hand, for some patients with severe static encephalopathy or global delays, the family may choose to maintain oral feeds for pleasure despite the known risks of aspiration and pulmonary injury. These considerations require a clear and detailed discussion of goals and risks between the family and clinicians [39].

Techniques to enhance oral feeding

  • In children with functional abnormalities, treatment is often led by speech and occupational therapists that specialize in swallowing. The specialist selects specific techniques to improve swallowing function based on individual patient characteristics:
  • In infants, change in the flow of liquids may significantly improve swallowing. These changes can be made by changing to a slow flow nipple.
  • Other feeding techniques include changes in the infant or child's position and posture during feeding, modification of bolus size, and alterations of consistency, shape, texture, and temperature of food. These techniques should be selected based on the result of the videofluoroscopic swallowing study (VFSS) or fiberoptic endoscopic evaluation of swallowing (FEES) (image 1) [3,40].
  • In children with delayed maturation, swallowing function may improve over time. In the interim, the techniques outlined above are used to support adequate nutrition and avoid aspiration. The type of feeding is then gradually advanced as the infant or child matures. Advances in feeding may be directed by repeat swallowing evaluation, including clinical assessment of feeding, with or without VFSS or FEES.

Gastrostomy feeds

Percutaneous gastrostomy tube placement should be considered for patients who are unable to safely consume enough calories by mouth. Some patients will require gastrostomy tubes to meet part or all of their nutritional needs. Oral-motor and swallowing therapy should be continued in patients in whom swallowing function is expected to improve, and gastrostomy tubes may be removed when no longer necessary.

Parents may initially be reluctant to have a gastrostomy tube placed because of concerns about losing pleasure of eating, discomfort, or cosmesis. The importance of preventing pulmonary aspiration, long-term benefits of improved nutrition, and reversibility of this procedure should be emphasized. In addition, gastrostomy tubes can be useful for administering medication and fluid, when needed.

General considerations about gastrostomy placement and enteral feeding are discussed in a separate topic review.

Management of gastroesophageal reflux

Aspiration Pneumonia

Antibiotic therapy is unequivocally indicated in patients

with aspiration pneumonia. The choice of antibiotics

should depend on the setting in which the

aspiration occurs as well as the patient’s general health

(Table 2). However, antibiotic agents with activity

against gram-negative organisms, such as third-generation

cephalosporins, fluoroquinolones, and piperacillin,

are usually required. Penicillin and clindamycin,

which are often called the standard antibiotic agents

for aspiration pneumonia, are inadequate for most patients

with aspiration pneumonia.78 Antibiotic agents

with specific anaerobic activity are not routinely warranted

and may be indicated only in patients with severe

periodontal disease, putrid sputum, or evidence

of necrotizing pneumonia or lung abscess on radiographs

of the chest.78,79

Aspiration Pneumonitis

The upper airway should be suctioned after a witnessed

aspiration of gastric contents. Endotracheal intubation

should be considered for patients who are

unable to protect their airway (for example, those with

a decreased level of consciousness). Although it is

common practice, the prophylactic use of antibiotics

in patients in whom aspiration is suspected or witnessed

is not recommended. Similarly, the use of antibiotics

shortly after aspiration in patients in whom

a fever, leukocytosis, or a pulmonary infiltrate develops

is discouraged, since the antibiotic may select

for more resistant organisms in patients with an uncomplicated

chemical pneumonitis. However, empirical

antibiotic therapy is appropriate for patients who

aspirate gastric contents and who have small-bowel

obstruction or other conditions associated with colonization

of the gastric contents. Antibiotic therapy

should be considered for patients with aspiration

pneumonitis that fails to resolve within 48 hours after

aspiration. Empirical therapy with broad-spectrum

agents is recommended (Table 2); antibiotics with

anaerobic activity are not routinely required. Sampling

of the lower respiratory tract (with a protected

specimen brush or by bronchoalveolar lavage) and

quantitative culture in intubated patients may allow

targeted antibiotic therapy and, in patients with negative

cultures, the discontinuation of antibiotics.

81,82

Corticosteroids have been used for decades in the

management of aspiration pneumonitis.

83

However,

there are limited data on the role of these agents. In

a prospective, placebo-controlled study, Sukumaran

and colleagues found that radiographically evident

lung injury improved more quickly in the patients given

corticosteroids than in those given placebo; however,

the patients given corticosteroids had a longer

stay in the intensive care unit, and there were no significant

differences between the two groups in the

incidence of complications or the outcome.

84,85

In a

case–control study, Wolfe and colleagues found that

pneumonia due to gram-negative bacteria was more

frequent after aspiration among patients treated with

corticosteroids than among those who were not.

86

Similarly, studies in animals have failed to demonstrate

a beneficial effect of corticosteroids on pulmonary

function, lung injury, alveolar–capillary permeability,

or outcome after acid aspiration.

87,88 Furthermore,

given the failure of two multicenter, randomized,

controlled trials to demonstrate a benefit of high-dose

corticosteroids in patients with the acute respiratory

distress syndrome, the administration of corticosteroids

cannot be recommended.89,90

References

Template:WH Template:WS